Healthcare provider profile · identity verified

Eric Charles Enberg, MD

Family Practice · DULUTH, MN · NPI 1144273749

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	767	196
Losartan Potassium	Losartan Potassium	612	160
Amlodipine Besylate	Amlodipine Besylate	372	109
Lisinopril	Lisinopril	330	91
Hydrochlorothiazide	Hydrochlorothiazide	287	81
Metformin Hcl	Metformin Hcl	266	79
Metoprolol Succinate	Metoprolol Succinate	261	70
Omeprazole	Omeprazole	256	67
Levothyroxine Sodium	Levothyroxine Sodium	238	54
Gabapentin	Gabapentin	217	65
Tamsulosin Hcl	Tamsulosin Hcl	210	55
Simvastatin	Simvastatin	197	46
Tramadol Hcl	Tramadol Hcl	153	30
Furosemide	Furosemide	145	46
Albuterol Sulfate Hfa	Albuterol Sulfate	140	41
Trazodone Hcl	Trazodone Hcl	138	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	137	30
Metformin Hcl Er	Metformin Hcl	136	32
Metoprolol Tartrate	Metoprolol Tartrate	134	35
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	130	25
Rosuvastatin Calcium	Rosuvastatin Calcium	115	36
Famotidine	Famotidine	103	21
Sertraline Hcl	Sertraline Hcl	102	26
Allopurinol	Allopurinol	94	23
Pantoprazole Sodium	Pantoprazole Sodium	94	28
Potassium Chloride	Potassium Chloride	87	25
Lorazepam	Lorazepam	84	19
Citalopram Hbr	Citalopram Hydrobromide	80	23
Alendronate Sodium	Alendronate Sodium	75	23
Ozempic	Semaglutide	73	15
Eliquis	Apixaban	72	24
Oxycodone Hcl	Oxycodone Hcl	71	13
Tizanidine Hcl	Tizanidine Hcl	69	15
Montelukast Sodium	Montelukast Sodium	66	14
Pravastatin Sodium	Pravastatin Sodium	66	17
Warfarin Sodium	Warfarin Sodium	66	17
Zolpidem Tartrate	Zolpidem Tartrate	60	14
Dutasteride	Dutasteride	58	12
Jardiance	Empagliflozin	58	11
Myrbetriq	Mirabegron	55	11
Ventolin Hfa	Albuterol Sulfate	55	11
Fluticasone Propionate	Fluticasone Propionate	54	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	54	suppressed
Atenolol	Atenolol	53	13
Finasteride	Finasteride	52	11
Pregabalin	Pregabalin	52	11
Clopidogrel	Clopidogrel Bisulfate	48	14
Glipizide	Glipizide	46	14
Ibuprofen	Ibuprofen	46	11
Paroxetine Hcl	Paroxetine Hcl	45	suppressed
Xarelto	Rivaroxaban	45	14
Fluoxetine Hcl	Fluoxetine Hcl	44	suppressed
Prednisone	Prednisone	42	22
Meloxicam	Meloxicam	40	suppressed
Mounjaro	Tirzepatide	40	suppressed
Clonazepam	Clonazepam	39	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	39	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Duloxetine Hcl	Duloxetine Hcl	37	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	suppressed
Donepezil Hcl	Donepezil Hcl	34	suppressed
Carvedilol	Carvedilol	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Baclofen	Baclofen	31	suppressed
Mirtazapine	Mirtazapine	31	suppressed
Divalproex Sodium Er	Divalproex Sodium	30	suppressed
Divalproex Sodium	Divalproex Sodium	29	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Nystatin	Nystatin	28	13
Spironolactone	Spironolactone	28	suppressed
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Morphine Sulfate Er	Morphine Sulfate	25	suppressed
Diazepam	Diazepam	24	suppressed
Methocarbamol	Methocarbamol	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	11
Varenicline Tartrate	Varenicline Tartrate	24	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Celecoxib	Celecoxib	21	suppressed
Estradiol	Estradiol	21	suppressed
Primidone	Primidone	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Minoxidil	Minoxidil	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Methylphenidate Er	Methylphenidate Hcl	19	suppressed
Ramipril	Ramipril	19	suppressed
Rybelsus	Semaglutide	19	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Carbamazepine	Carbamazepine	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Naproxen	Naproxen	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Clonidine	Clonidine	14	suppressed
Dulera	Mometasone/Formoterol	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Cilostazol	Cilostazol	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Galantamine Hbr	Galantamine Hbr	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Novolog	Insulin Aspart	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Acetazolamide	Acetazolamide	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error